12/31/2019
Cash & ST Marketable Securities $1,533.3
Total Liabilities (ST & LT) $1,512.4
Interest Expense (annual est.) $60.3
Return on Equity 24.1%
*millions
No concerns about financial position…
| Date | Sales (millions) | % Chg. |
| 3/2018 | 184.4 | 30% |
| 6/2018 | 242.5 | 42% |
| 9/2018 | 266.7 | 44% |
| 12/2018 | 338 | 53% |
| 3/2019 | 280.5 | 52% |
| 6/2019 | 336.4 | 39% |
| 9/2019 | 396.3 | 49% |
| 12/2019 | 462.8 | 37% |
Investor Concerns
It’s expensive to continually update and develop new products in the medical device space.
Other larger medical device companies are entering this space. Abbot Laboratories is the latest
Investor Confidence
The popularity of their device continues to rise among doctors and end users. Sales continue to increase quarter over quarter. They have reaffirmed full year guidance for 2020.
https://investors.dexcom.com/node/19051/html#s0F6B1E295F4D5BC1802315D142DABB8A
For What it's Worth 